Mammodol is prescribed to improve the functional state of women with fibrocystic breast disease; mastodynia; premenstrual syndrome; violations of the menstrual cycle; in order to prevent the development of hyperplastic processes in the mammary glands.
Indole-3-carbinol – 200.0 mg, cane extract – 100.0 mg, lactose – 88.0 mg, calcium stearate – 8.0 mg, Aerosil-4.0 mg.
400 mg capsules.
Properties of active ingredients
Indole-3-carbinol (I3C) has a pronounced positive effect on dyshormonal diseases of the mammary glands. I3C promotes selective inhibition of the growth of transformed cells and induction of apoptosis. The antiproliferative effect of I3C is realized by several mechanisms, the main of which is the normalization of the metabolism and balance of estrogens, a decrease in the formation of the pathological metabolite of 16ά-hydroxyestrone, which has pronounced carcinogenic properties.
I3C blocks both hormone-dependent and hormone-independent pathways of pathological cell proliferation – it neutralizes the effect of epidermal and insulin-like growth factors that stimulate cell proliferation in the mammary glands and uterus, inhibits the effect of anti-inflammatory cytokines. I3C restores the work of the BRCA antitumor defense genes, blocks the synthesis of the E7 oncoprotein in epithelial cells infected with the human papillomavirus.
Common rod (Agnus Castus), having a dopaminergic effect, helps to reduce the level of prolactin, which indirectly leads to the establishment of a physiological ratio of female sex hormones (estrogens and progesterone), an improvement in the morphofunctional state of the mammary glands, a decrease in the formation of connective tissue in the mammary glands and prevention of expansion of the milk ducts , relief of pain syndrome, normalization of the menstrual cycle, mitigation of symptoms of premenstrual syndrome, improvement of the psycho-emotional state.
Indications for use
Mammodol is recommended as an additional source of indole-3-carbinol, biologically active compounds of the common rod. Promotes the normalization of metabolic processes in the mammary glands in women. Mammodol is prescribed to improve the functional state of women with fibrocystic breast disease; mastodynia; premenstrual syndrome; violations of the menstrual cycle; in order to prevent the development of hyperplastic processes in the mammary glands.
Method of administration and dosage
Women 1-2 capsules per day during or after meals. Drink with plenty of water. The course of admission is 3 months. In the future, the frequency and duration of Mammodol use should be agreed with your doctor.
Individual sensitivity to components, pregnancy, lactation, children under 14 years old. The simultaneous intake of foods that reduce the acidity of the stomach is not recommended.
Store Mammodol in a dry place in its original packaging, at a temperature not exceeding 25 degrees Celsius.